Scheme of Limb Warming Blanket Combined With Dexmedetomidine

May 4, 2023 updated by: Wei Fan, Jincheng General Hospital

Clinical Effect Observation of Lower Limb Warming Blanket Combined With Dexmedetomidine in Preventing Postoperative Delirium and Chills in Elderly Patients Undergoing Spinal Surgery

Objective: To observe the clinical effect of lower limb warming blanket combined with dexmedetomidine (DEX) in preventing postoperative delirium (POD) and chills in elderly patients undergoing spinal surgery. Methods: A total of 160 elderly patients undergoing posterior spinal surgery under general anesthesia were selected and divided into control group (group N), heating group (group T), DEX group (group D) and heating combined with DEX group (group TD) according to the random number table method, 40 cases in each group. T group and TD group routine insulation and lower limb heating blanket. DEX was injected in group D and group TD. The dosage of anesthetics, the changes of body temperature and heart rate at different time points during operation, and the occurrence of postoperative chills and POD were compared among the groups.

Study Overview

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanxi
      • Jincheng, Shanxi, China, 048006
        • Jincheng General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: between 65-80 years old;
  • American Society of Anesthesiologists (ASA) grade II-III;
  • Normal body temperature before operation;
  • the operation time was 2-4 hours

Exclusion Criteria:

  • Preoperative fever or hypothermia (body temperature≥37.5 ℃ or≤35.5℃ on the day of operation);
  • Body mass index (BMI) >30 kg/m2;
  • The existence of heart, brain, lung, kidney and other important organs and circulatory system, respiratory system, immune system, central nervous system diseases;
  • Patients who had taken antipsychotic drugs or β-blockers before surgery would have a greater impact on intraoperative body temperature and other patients who could not effectively cooperate with this study;
  • Patients with operation time more than 5 hours

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group (group N)
Active Comparator: heating group (group T)
Beijing Maikang Medical Device Co., Ltd., Model: Warm-1-1.
Active Comparator: DEX group (group D)
Dexmetomidine (H20183219) 0.4μg / (kg·min);
Experimental: heating combined with DEX group (group TD)
Beijing Maikang Medical Device Co., Ltd., Model: Warm-1-1.
Dexmetomidine (H20183219) 0.4μg / (kg·min);

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative vital signs monitoring
Time Frame: 1 hour
nasopharyngeal temperature
1 hour
Intraoperative vital signs monitoring
Time Frame: 2 hour
nasopharyngeal temperature
2 hour
Intraoperative vital signs monitoring
Time Frame: 3 hour
nasopharyngeal temperature
3 hour
The incidence of postoperative chills
Time Frame: 1 hour
chills refer to the Wrench classification criteria as follows : 0: no chills; grade 1: peripheral vascular contraction, vertical hair, but no muscle fibrillation; level 2: only one muscle group had muscle fibrillation; grade 3: muscle fibrillation in multiple groups; level 4: general tremor; ≥ 1 level was judged to have chills.
1 hour
The incidence of POD after operation
Time Frame: 1 day
The results of POD in each group were recorded, and the POD was evaluated by CAM-CR scale. The incidence of POD at 24,48 and 72 h after operation was compared among the groups
1 day
Postoperative extubation time
Time Frame: 1 hour
The recovery time from the end of surgery to extubation was recorded.
1 hour
Postoperative incision infection rate
Time Frame: 1 hour
The incidence of postoperative incision infection was recorded.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

December 30, 2022

Study Completion (Actual)

January 25, 2023

Study Registration Dates

First Submitted

April 23, 2023

First Submitted That Met QC Criteria

May 4, 2023

First Posted (Actual)

May 12, 2023

Study Record Updates

Last Update Posted (Actual)

May 12, 2023

Last Update Submitted That Met QC Criteria

May 4, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe